{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:53:38Z","timestamp":1790790818118,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,13]]},"DOI":"10.7759\/cureus.22177","type":"journal-article","created":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T16:37:00Z","timestamp":1644770220000},"source":"Crossref","is-referenced-by-count":7,"title":["Evaluation and Classification of Mast Cell Disorders: A Difficult to Manage Pathology in Clinical Practice"],"prefix":"10.7759","author":[{"given":"Polliana Mihaela","family":"Leru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Beitrage sur Theorie und Praxis der Histologischen Farbung","author":"Ehrlich P","year":"1878","unstructured":"Ehrlich P. Beitrage sur Theorie und Praxis der Histologischen Farbung. 1878."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020464","article-title":"Mast cells: fascinating but still elusive after 140 years from their discovery","volume":"21","author":"Varricchi G","year":"2020","unstructured":"Varricchi G, Marone G. Mast cells: fascinating but still elusive after 140 years from their discovery. Int J Mol Sci. 2020, 21:464. 10.3390\/ijms21020464","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00569","article-title":"Mast cell mediators: their differential release and the secretory pathways involved","volume":"5","author":"Moon TC","year":"2014","unstructured":"Moon TC, Befus AD, Kulka M. Mast cell mediators: their differential release and the secretory pathways involved. Front Immunol. 2014, 5:569. 10.3389\/fimmu.2014.00569","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/all.13668","article-title":"New insights into the origin of mast cells","volume":"74","author":"Nilsson G","year":"2019","unstructured":"Nilsson G, Dahlin JS. New insights into the origin of mast cells. Allergy. 2019, 74:844-5. 10.1111\/all.13668","journal-title":"Allergy"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.02.004","article-title":"Regulation of the pleiotropic effects of tissue-resident mast cells","volume":"144","author":"Huber M","year":"2019","unstructured":"Huber M, Cato AC, Ainooson GK, et al.. Regulation of the pleiotropic effects of tissue-resident mast cells. J Allergy Clin Immunol. 2019, 144:S31-45. 10.1016\/j.jaci.2019.02.004","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1596800","article-title":"Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?","volume":"15","author":"Theoharides TC","year":"2019","unstructured":"Theoharides TC, Tsilioni I, Ren H. Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?. Expert Rev Clin Immunol. 2019, 15:639-56. 10.1080\/1744666X.2019.1596800","journal-title":"Expert Rev Clin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone KD","year":"2010","unstructured":"Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010, 125:S73-80. 10.1016\/j.jaci.2009.11.017","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0145-2126(01)00046-7","article-title":"Mastocytosis: molecular mechanisms and clinical disease heterogeneity","volume":"25","author":"Metcalfe DD","year":"2001","unstructured":"Metcalfe DD, Akin C. Mastocytosis: molecular mechanisms and clinical disease heterogeneity. Leuk Res. 2001, 25:577-82. 10.1016\/s0145-2126(01)00046-7","journal-title":"Leuk Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2019.09.002","article-title":"Mast cell activation. When the whole is greater than the sum of its parts","volume":"104","author":"Khokhar D","year":"2020","unstructured":"Khokhar D, Akin C. Mast cell activation. When the whole is greater than the sum of its parts. Med Clin North Am. 2020, 104:177-87. 10.1016\/j.mcna.2019.09.002","journal-title":"Med Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides TC","year":"2015","unstructured":"Theoharides TC, Valent P, Akin C. Mast cells, mastocytosis, and related disorders. N Engl J Med. 2015, 373:163-72. 10.1056\/NEJMra1409760","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent P","year":"2017","unstructured":"Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017, 129:1420-7. 10.1182\/blood-2016-09-731893","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25371","article-title":"Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management","volume":"94","author":"Pardanani A","year":"2019","unstructured":"Pardanani A. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management. Am J Hematol. 2019, 94:363-77. 10.1002\/ajh.25371","journal-title":"Am J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/all.12436","article-title":"Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis","volume":"69","author":"Valent P","year":"2014","unstructured":"Valent P, Escribano L, Broesby-Olsen S, et al.. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis. Allergy. 2014, 69:1267-74. 10.1111\/all.12436","journal-title":"Allergy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22125","article-title":"Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology","volume":"53","author":"Uzzaman A","year":"2009","unstructured":"Uzzaman A, Maric I, Noel P, Kettelhut BV, Metcalfe DD, Carter MC. Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer. 2009, 53:629-34. 10.1002\/pbc.22125","journal-title":"Pediatr Blood Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-453183","article-title":"How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage)","volume":"121","author":"Pardanani A","year":"2013","unstructured":"Pardanani A. How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage). Blood. 2013, 121:3085-94. 10.1182\/blood-2013-01-453183","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.117","article-title":"Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis","volume":"27","author":"Berezowska S","year":"2014","unstructured":"Berezowska S, Flaig MJ, Ru\u00ebff F, et al.. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis. Mod Pathol. 2014, 27:19-29. 10.1038\/modpathol.2013.117","journal-title":"Mod Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2009.02108.x","article-title":"How much specific is the association between Hymenoptera venom allergy and mastocytosis?","volume":"64","author":"Bonadonna P","year":"2009","unstructured":"Bonadonna P, Zanotti R, Pagani M, et al.. How much specific is the association between Hymenoptera venom allergy and mastocytosis?. Allergy. 2009, 64:1379-82. 10.1111\/j.1398-9995.2009.02108.x","journal-title":"Allergy"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1515\/dx-2020-0005","article-title":"Diagnosis of mast cell activation syndrome: a global \"consensus-2\"","volume":"8","author":"Afrin LB","year":"2021","unstructured":"Afrin LB, Ackerley MB, Bluestein LS, et al.. Diagnosis of mast cell activation syndrome: a global \"consensus-2\". Diagnosis (Berl). 2021, 8:137-52. 10.1515\/dx-2020-0005","journal-title":"Diagnosis (Berl)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20122976","article-title":"Multidisciplinary challenges in mastocytosis and how to address with personalized medicine approaches","volume":"20","author":"Valent P","year":"2019","unstructured":"Valent P, Akin C, Gleixner KV, Sperr WR, Reiter A, Arock M, Triggiani M. Multidisciplinary challenges in mastocytosis and how to address with personalized medicine approaches. Int J Mol Sci. 2019, 20:2976. 10.3390\/ijms20122976","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8474","article-title":"Acquired angioedema induced by angiotensin-converting enzyme inhibitors - experience of a hospital-based allergy center","volume":"20","author":"Leru PM","year":"2020","unstructured":"Leru PM, Anton VF, Bocsan C, Muntean A, Boda D. Acquired angioedema induced by angiotensin-converting enzyme inhibitors - experience of a hospital-based allergy center. Exp Ther Med. 2020, 20:68-72. 10.3892\/etm.2020.8474","journal-title":"Exp Ther Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1515\/rjim-2015-0015","article-title":"Romanian allergology in the actual European context","volume":"53","author":"Leru PM","year":"2015","unstructured":"Leru PM, Deleanu DM. Romanian allergology in the actual European context. Rom J Intern Med. 2015, 53:111-7. 10.1515\/rjim-2015-0015","journal-title":"Rom J Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.06.007","article-title":"Mast cell activation syndromes","volume":"140","author":"Akin C","year":"2017","unstructured":"Akin C. Mast cell activation syndromes. J Allergy Clin Immunol. 2017, 140:349-55. 10.1016\/j.jaci.2017.06.007","journal-title":"J Allergy Clin Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8947","article-title":"Mast cell activation syndromes - evaluation of current diagnostic criteria and laboratory tools in clinical practice (review)","volume":"20","author":"Leru PM","year":"2020","unstructured":"Leru PM, Anton VF, Ureche C, Zurac S, Bratu O, Neagoe CD. Mast cell activation syndromes - evaluation of current diagnostic criteria and laboratory tools in clinical practice (review). Exp Ther Med. 2020, 20:2348-51. 10.3892\/etm.2020.8947","journal-title":"Exp Ther Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.04.001","article-title":"Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes","volume":"35","author":"Picard M","year":"2013","unstructured":"Picard M, Giavina-Bianchi P, Mezzano V, Castells M. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes. Clin Ther. 2013, 35:548-62. 10.1016\/j.clinthera.2013.04.001","journal-title":"Clin Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent P","year":"2019","unstructured":"Valent P, Akin C, Bonadonna P, et al.. Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome. J Allergy Clin Immunol Pract. 2019, 7:1125-1133.e1. 10.1016\/j.jaip.2019.01.006","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.08.023","article-title":"AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management","volume":"144","author":"Weiler CR","year":"2019","unstructured":"Weiler CR, Austen KF, Akin C, et al.. AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management. J Allergy Clin Immunol. 2019, 144:883-96. 10.1016\/j.jaci.2019.08.023","journal-title":"J Allergy Clin Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2015.01.010","article-title":"Mast cell activation syndromes presenting as anaphylaxis","volume":"35","author":"Akin C","year":"2015","unstructured":"Akin C. Mast cell activation syndromes presenting as anaphylaxis. Immunol Allergy Clin North Am. 2015, 35:277-85. 10.1016\/j.iac.2015.01.010","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00103","article-title":"Bidirectional mast cell- eosinophil interactions in inflammatory disorders and cancer","volume":"4","author":"Galdiero MR","year":"2017","unstructured":"Galdiero MR, Varricchi G, Seaf M, Marone G, Levi-Schaffer F, Marone G. Bidirectional mast cell- eosinophil interactions in inflammatory disorders and cancer. Front Med (Lausanne). 2017, 4:103. 10.3389\/fmed.2017.00103","journal-title":"Front Med (Lausanne)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0632-4","article-title":"Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry","volume":"34","author":"Kluin-Nelemans HC","year":"2020","unstructured":"Kluin-Nelemans HC, Reiter A, Illerhaus A, et al.. Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry. Leukemia. 2020, 34:1090-101. 10.1038\/s41375-019-0632-4","journal-title":"Leukemia"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-019-0887-x","article-title":"Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations","volume":"19","author":"Khoury P","year":"2019","unstructured":"Khoury P, Lyons JJ. Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations. Curr Allergy Asthma Rep. 2019, 19:55. 10.1007\/s11882-019-0887-x","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref31","article-title":"Mastocytosis and allergic diseases","volume":"24","author":"Bonadona P","year":"2014","unstructured":"Bonadona P, Lombardo C, Zanotti R. Mastocytosis and allergic diseases. J Investig Allergol Clin Immunol. 2014, 24:288-97.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano L","year":"2009","unstructured":"Escribano L, Alvarez-Twose I, S\u00e1nchez-Mu\u00f1oz L, et al.. Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol. 2009, 124:514-21. 10.1016\/j.jaci.2009.05.003","journal-title":"J Allergy Clin Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.08.022","article-title":"Mast cell activation syndrome: tools for diagnosis and differential diagnosis","volume":"8","author":"Weiler CR","year":"2020","unstructured":"Weiler CR. Mast cell activation syndrome: tools for diagnosis and differential diagnosis. J Allergy Clin Immunol Pract. 2020, 8:498-506. 10.1016\/j.jaip.2019.08.022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2016.1161231","article-title":"Often seen, rarely recognized: mast cell activation disease - a guide to diagnosis and therapeutic options","volume":"48","author":"Afrin LB","year":"2016","unstructured":"Afrin LB, Butterfield JH, Raithel M, Molderings GJ. Often seen, rarely recognized: mast cell activation disease - a guide to diagnosis and therapeutic options. Ann Med. 2016, 48:190-201. 10.3109\/07853890.2016.1161231","journal-title":"Ann Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.11.045","article-title":"Doctor, I think I am suffering from MCAS: differential diagnosis and separating facts from fiction","volume":"7","author":"Valent P","year":"2019","unstructured":"Valent P, Akin C. Doctor, I think I am suffering from MCAS: differential diagnosis and separating facts from fiction. J Allergy Clin Immunol Pract. 2019, 7:1109-14. 10.1016\/j.jaip.2018.11.045","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.09.024","article-title":"The Data Registry of the European Competence Network on Mastocytosis (ECNM): set up, projects, and perspectives","volume":"7","author":"Valent P","year":"2019","unstructured":"Valent P, Oude Elberink JN, Gorska A, et al.. The Data Registry of the European Competence Network on Mastocytosis (ECNM): set up, projects, and perspectives. J Allergy Clin Immunol Pract. 2019, 7:81-7. 10.1016\/j.jaip.2018.09.024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent P","year":"2021","unstructured":"Valent P, Akin C, Hartmann K, et al.. Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal. Hemasphere. 2021, 5:e646. 10.1097\/HS9.0000000000000646","journal-title":"Hemasphere"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/84794-evaluation-and-classification-of-mast-cell-disorders-a-difficult-to-manage-pathology-in-clinical-practice","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:40Z","timestamp":1707507460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/84794-evaluation-and-classification-of-mast-cell-disorders-a-difficult-to-manage-pathology-in-clinical-practice"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,13]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.22177","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,13]]}}}